Latest Breaking News On - Veracyte diagnostics platform - Page 1 : comparemela.com

Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer

Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMatthewa lobergSara ahmadiJoshua klopperRabail sadiqBoston convention exhibition centerVanderbilt university medical centerEndocrine societyVeracyte incJohns hopkins university school of medicineMolecular testingThyroid nodulesGenomic resourceIntelligent discoveryBoston conventionExhibition center

Veracyte to Participate in Upcoming Investor Conferences

Veracyte to Participate in Upcoming Investor Conferences
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairVeracyte incUpcoming investorCrossroads conferenceAnnual growth stock conferenceVeracyte diagnostics platform

Veracyte, Inc (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript

Veracyte, Inc (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesMason carricoWilliam blairMarc stapleyJi namRebecca chambersShayla gormanAndrew brackmannBiggest real estate companiesExchange commissionMorgan stanleyVeracyte incAmerican cancer societyCall transcript mayVeracyte first quarterResults conference

Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024

Veracyte, Inc. announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a conference call and webcast to discuss financial results and.

Veracyte incConference callRelease first quarterVeracyte diagnostics platform

New Study Shows Veracyte s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance

Veracyte, Inc. , a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance for prostate.

Elai davicioniVeracyte incResearch useNational comprehensive cancer networkActive surveillanceDecipher prostate genomic classifierDecipher prostateGenomic resourceIntelligent discoveryVeracyte diagnostics platformDecipher prostate genomicResearch use onlyAnnual reportNational comprehensive cancer